Ra Pharmaceuticals, Inc. portfolio

United States

Every trademark Ra Pharmaceuticals, Inc. holds, newest filings first. The portfolio has 8 marks.

Company overview Get this data via the API

Search this portfolio

Trademarks on file: 8
Active: 0
Owner names grouped: 1

Portfolio

All trademarks

50 marks per page, newest filing date first. Pick an office to narrow the list.

Mark	Status	Office	Classes	Filed
ZILBRYSQ ZILUCOPLAN	abandoned	USPTO	5, 10	2020-05-15
ZILBRYSQ	abandoned	USPTO	5, 10	2020-03-27
RA PHARMACEUTICALS	cancelled	USPTO	5	2016-01-06
RA PHARMACEUTICALS	cancelled	USPTO	42	2016-01-06
RA PHARMA	cancelled	USPTO	5	2016-01-06
RA PHARMA	cancelled	USPTO	42	2016-01-06
RA PHARMA	cancelled	USPTO	5	2016-01-06
RA PHARMA	cancelled	USPTO	42	2016-01-06

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Ra Pharmaceuticals, Inc.'s full portfolio into your own product.

GET/v1/entities/{id}/trademarks
Every trademark in the portfolio, filterable by office and class
GET/v1/entities/{id}/analytics
Portfolio totals, disputes and ownership changes
GET/v1/entities/{id}
Company record, ticker, LEI and owner names

Get API key View docs

GET /v1/entities/{id}/trademarks

ID=ent_019eb70a-af8c-72ff-bb0e-61a2e386b4e1
curl https://api.signa.so/v1/entities/$ID/trademarks \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "object": "list",
  "data": [
    {
      "id": "tm_019d2bb3-e962-74ae-80dd-ebb6f63373b4",
      "mark_text": "ZILBRYSQ ZILUCOPLAN",
      "office_code": "US",
      "status": {
        "stage": "abandoned"
      },
      "filing_date": "2020-05-15"
    },
    {
      "id": "tm_019d2b87-c70d-7067-a5e3-2573f4b56820",
      "mark_text": "ZILBRYSQ",
      "office_code": "US",
      "status": {
        "stage": "abandoned"
      },
      "filing_date": "2020-03-27"
    }
  ],
  "has_more": false
}